44 /100
MEDIUM RISK
Score updated Jul 14, 2026

HAVA — Harvard Ave Acquisition Corporation Dilution Risk Tracker

Track HAVA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HAVA — Get alerts when the score changes →

As of July 14, 2026, Harvard Ave Acquisition Corporation (HAVA) has a DilutionWatch DilutionScore of 44/100, rated MEDIUM dilution risk. Harvard Ave Acquisition Corporation has a market capitalization of $208.59M, 4.83M shares outstanding, 35 institutional holders tracked.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
40
📊 Float Risk
7
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for HAVA.
🔔 Track HAVA — Get forecast alerts →

💹 Market Data

Market Cap$208.59M
Shares Outstanding4.83M
FloatN/A
Cash$867.7K
Debt$328.9K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 145.5% shares (2026Q1 vs prior)
35 institutional holders · 12.13M shares
#1 MILLENNIUM MANAGEMENT LLC 950.0K shares
#2 WHITEBOX ADVISORS LLC 750.0K shares
#3 Hudson Bay Capital Management LP 750.0K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.3K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for HAVA Shareholders

Harvard Ave Acquisition Corporation (HAVA) has a DilutionScore of 44/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for HAVA shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for HAVA in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for HAVA alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track HAVA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HAVA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for HAVA
📊 HAVA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 HAVA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.